Patient Pathfinder: Clinical Trials
Clinical Trials for Breast Cancer
Every life-saving or life-extending treatment that’s available today for cancer started its journey in a clinical trial. A clinical trial is a study that helps doctors better understand cancer, and discover safer and more effective ways to treat it.
Clinical trials also give patients a chance to try a treatment before it’s approved by the U.S. Food and Drug Administration.
There are 1827 active Breast Cancer trials
Adherence Intervention in Patients With Metastatic Breast Cancer
Study Type: Interventional
A Study of Contrast-Enhanced Mammography (CEM) Scans in People With Breast Cancer
Study Type: Observational
A Study of Lenvatinib, Pembrolizumab, and Fulvestrant in People With Breast Cancer
Study Type: Interventional Phase 1
Biennial CEM in Women With a Personal History of Breast Cancer
Study Type: Interventional
MIRAI-MRI: Comparing Screening MRI for Patients at High Risk for Breast Cancer Identified by Mirai and Tyrer-Cuzick
Study Type: Interventional
Shorter Chemo-Immunotherapy Without Anthracycline Drugs for Early-Stage Triple Negative Breast Cancer
Study Type: Interventional Phase 3
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2)
Study Type: Interventional Phase 3
Breast Cancer Pre-habilitation and Prospective Surveillance to Prevent, Detect, and Optimize Physical and Function
Study Type: Interventional Phase 1
There are 1827 active Breast Cancer trials
Filter Results
Phase
Study Type
Need more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start NowNeed more help finding a clinical trial that's the right fit?
Explore our Clinical Trial Finder.
Start Now